Lynette Denny

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Cornelia L. Trimble, Matthew P. Morrow, Kimberly A. Kraynyak et al. · The Lancet · 2015 · 714 citations

Medicine, Immunology, Oncology +17

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

F. Xavier Bosch, Thomas R. Broker, David Forman et al. · Vaccine · 2013 · 440 citations · Full text

Life Sciences, Infectious Disease Control, Infectious Diseases +16

Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings

Sue J. Goldie, Louise Kuhn, Lynette Denny et al. · JAMA · 2001 · 343 citations

Medicine, Gynecology, Pathology +17

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

F. Xavier Bosch, Thomas R. Broker, David Forman et al. · Vaccine · 2013 · 331 citations

Life Sciences, Infectious Disease Control, Infectious Diseases +16

Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer

Imran Morhason‐Bello, Folakemi T. Odedina, Timothy R. Rebbeck et al. · The Lancet Oncology · 2013 · 308 citations

Public Health, Health Policy, Oncology +14